Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Harvard Business School
McKesson
Colorcon
Mallinckrodt

Last Updated: November 29, 2022

Lisinopril - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for lisinopril and what is the scope of patent protection?

Lisinopril is the generic ingredient in four branded drugs marketed by Azurity, Accord Hlthcare, Ascent Pharms Inc, Atlantide, Aurobindo, Chartwell Rx, Corepharma, Graviti Pharms, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Prinston Inc, Strides Pharma, Sun Pharm Inds Ltd, Teva, Watson Labs, Yiling, Merck, and Almatica, and is included in twenty-two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lisinopril has ten patent family members in eight countries.

There are twenty-one drug master file entries for lisinopril. Forty-four suppliers are listed for this compound.

Drug Prices for lisinopril

See drug prices for lisinopril

Drug Sales Revenue Trends for lisinopril

See drug sales revenues for lisinopril

Recent Clinical Trials for lisinopril

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of RochesterEarly Phase 1
Medical College of WisconsinEarly Phase 1
Fondazione SchenaPhase 4

See all lisinopril clinical trials

Pharmacology for lisinopril
Medical Subject Heading (MeSH) Categories for lisinopril
Paragraph IV (Patent) Challenges for LISINOPRIL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
QBRELIS Oral Solution lisinopril 1 mg/mL 208401 1 2019-10-24

US Patents and Regulatory Information for lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva LISINOPRIL lisinopril TABLET;ORAL 075783-003 Jul 1, 2002 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Strides Pharma LISINOPRIL lisinopril TABLET;ORAL 076071-004 Jul 1, 2002 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merck PRINIVIL lisinopril TABLET;ORAL 019558-004 Oct 25, 1988 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Prinston Inc LISINOPRIL lisinopril TABLET;ORAL 076164-003 Jul 1, 2002 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for lisinopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica ZESTRIL lisinopril TABLET;ORAL 019777-006 Jan 20, 1999 See Plans and Pricing See Plans and Pricing
Almatica ZESTRIL lisinopril TABLET;ORAL 019777-001 May 19, 1988 See Plans and Pricing See Plans and Pricing
Almatica ZESTRIL lisinopril TABLET;ORAL 019777-002 May 19, 1988 See Plans and Pricing See Plans and Pricing
Merck PRINIVIL lisinopril TABLET;ORAL 019558-006 Jan 28, 1994 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Boehringer Ingelheim
Baxter
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.